Redwood Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-783,983
Closed -$20M 144
2018
Q2
$20M Sell
783,983
-45,599
-5% -$1.06M 1.39% 18
2018
Q1
$16.7M Buy
+829,582
New +$19.4M 1.2% 34
2016
Q4
Sell
-155,348
Closed -$4.35M 187
2016
Q3
$4.35M Buy
155,348
+28,241
+22% +$948K 0.33% 97
2016
Q2
$4.45M Buy
127,107
+27,378
+27% +$861K 0.41% 72
2016
Q1
$2.73M Buy
99,729
+32,297
+48% +$951K 0.27% 92
2015
Q4
$2.31M Buy
+67,432
New +$2.1M 0.25% 67

Other funds holding DPLO

Redwood Investments's DPLO Position: Q3 2018 in Review

Redwood Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 783,983 shares — an estimated $20M sold.

Redwood Investments first reported a position in DPLO in Q4 2015 and held it in 6 quarters. The position peaked at $20M in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Redwood Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Redwood Investments sold 783,983 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $20M.
  • Redwood Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 6 quarters.
  • Redwood Investments's DIPLOMAT PHARMACY, INC. position peaked at $20M in Q2 2018.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Redwood Investments's 13F filing for Q3 2018, filed 13 Nov 2018.